Skip to main content

Innovation in Drug Research and Development for Prevalent Chronic Diseases Proceedings of a Workshop (2021) / Chapter Skim
Currently Skimming:

1 Introduction
Pages 1-4

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... , a trade association that represents bio technology companies and related organizations, venture investments (i.e., early stage funding) and innovation for drug development in several highly prevalent chronic diseases -- depression, chronic pain conditions, addiction, type 2 diabetes, obesity, Alzheimer's disease (AD)
Read the entire page →
From page 2...
... Statements, recommendations, and opinions expressed are those of individual presenters and participants and are not endorsed or verified by the National Academies of Sciences, Engineering, and Medicine, and they should not be construed as reflecting any group consensus. The workshop agenda and workshop speaker biographical sketches can be found in Appendixes A and B, respectively.
Read the entire page →
From page 3...
... The public workshop will feature invited presentations and discussions to: • Discuss the unique cross-cutting challenges to increased investment in early-stage research and late-stage drug development for prevalent chronic diseases (e.g., Do we have promising targets? Are the regulatory requirements predictable?
Read the entire page →
From page 4...
... 2019b. The state of innovation in highly prevalent chronic diseases.
Read the entire page →

Key Terms

  • prevalent chronic
  • highly prevalent
  • accessed july
  • planning committee
  • chronic disease

  • congressional budget
  • highlight opportunities
  • budget office
  • invited presentations
  • lent chronic

  • chronic pain
  • prevent prevalent
  • treat prevalent
  • major health
  • poor health

  • health promotion
  • digital health
  • pain conditions
  • explores practical
  • leading driver

  • increased investment
  • drug discovery
  • trial participation
  • using digital
  • clinical trials

  • workshop speaker
  • leading cause
  • require additional
  • trade association
  • speaker biographical


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.